Literature DB >> 15632201

The stress-inducted proteins RTP801 and RTP801L are negative regulators of the mammalian target of rapamycin pathway.

Michael N Corradetti1, Ken Inoki, Kun-Liang Guan.   

Abstract

The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that plays an essential role in cell growth control. mTOR stimulates cell growth by phosphorylating p70 ribosomal S6 kinase (S6K) and eukaryote initiation factor 4E-binding protein 1 (4EBP1). The mTOR pathway is regulated by a wide variety of cellular signals, including mitogenic growth factors, nutrients, cellular energy levels, and stress conditions. Recent studies have proposed several mechanisms to explain how mTOR is regulated by growth factors and cellular energy levels. However, little is known as to how mTOR is regulated by stress conditions. We observed that two stress-induced proteins, RTP801/Redd1 and RTP801L/Redd2, potently inhibit signaling through mTOR. Our data support that RTP801 and RTP801L work downstream of AKT and upstream of TSC2 to inhibit mTOR functions. These results add a new dimension to mTOR pathway regulation and provide a possible molecular mechanism of how cellular stress conditions may regulate mTOR function.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15632201     DOI: 10.1074/jbc.C400557200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  116 in total

1.  Attenuation of TORC1 signaling delays replicative and oncogenic RAS-induced senescence.

Authors:  Marina Kolesnichenko; Lixin Hong; Rong Liao; Peter K Vogt; Peiqing Sun
Journal:  Cell Cycle       Date:  2012-06-15       Impact factor: 4.534

Review 2.  Control of translation initiation through integration of signals generated by hormones, nutrients, and exercise.

Authors:  Scot R Kimball; Leonard S Jefferson
Journal:  J Biol Chem       Date:  2010-06-24       Impact factor: 5.157

3.  ERK1/2 phosphorylate Raptor to promote Ras-dependent activation of mTOR complex 1 (mTORC1).

Authors:  Audrey Carriere; Yves Romeo; Hugo A Acosta-Jaquez; Julie Moreau; Eric Bonneil; Pierre Thibault; Diane C Fingar; Philippe P Roux
Journal:  J Biol Chem       Date:  2010-11-11       Impact factor: 5.157

Review 4.  Regulation of mammalian target of rapamycin complex 1 (mTORC1) by hypoxia: causes and consequences.

Authors:  Hakan Cam; Peter J Houghton
Journal:  Target Oncol       Date:  2011-04-16       Impact factor: 4.493

Review 5.  Cellular mechanisms regulating protein synthesis and skeletal muscle hypertrophy in animals.

Authors:  Mitsunori Miyazaki; Karyn A Esser
Journal:  J Appl Physiol (1985)       Date:  2008-11-26

6.  Regulated in DNA damage and development 1 (REDD1) promotes cell survival during serum deprivation by sustaining repression of signaling through the mechanistic target of rapamycin in complex 1 (mTORC1).

Authors:  Michael D Dennis; Nora K McGhee; Leonard S Jefferson; Scot R Kimball
Journal:  Cell Signal       Date:  2013-09-07       Impact factor: 4.315

7.  Bile acid-induced inflammatory signaling in mice lacking Foxa2 in the liver leads to activation of mTOR and age-onset obesity.

Authors:  Irina Mikhailovna Bochkis; Soona Shin; Klaus Hermann Kaestner
Journal:  Mol Metab       Date:  2013-08-24       Impact factor: 7.422

8.  The folliculin tumor suppressor is a GAP for the RagC/D GTPases that signal amino acid levels to mTORC1.

Authors:  Liron Bar-Peled; Lynne Chantranupong; Zhi-Yang Tsun; Roberto Zoncu; Tim Wang; Choah Kim; Eric Spooner; David M Sabatini
Journal:  Mol Cell       Date:  2013-10-03       Impact factor: 17.970

9.  Hypoxia-induced energy stress inhibits the mTOR pathway by activating an AMPK/REDD1 signaling axis in head and neck squamous cell carcinoma.

Authors:  Abraham Schneider; Rania H Younis; J Silvio Gutkind
Journal:  Neoplasia       Date:  2008-11       Impact factor: 5.715

10.  Promoting axon regeneration in the adult CNS by modulation of the PTEN/mTOR pathway.

Authors:  Kevin Kyungsuk Park; Kai Liu; Yang Hu; Patrice D Smith; Chen Wang; Bin Cai; Bengang Xu; Lauren Connolly; Ioannis Kramvis; Mustafa Sahin; Zhigang He
Journal:  Science       Date:  2008-11-07       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.